Lactulose treatment improves cognition, quality of life and intestinal microbiota in minimal hepatic encephalopathy patients: results from a multi-center, randomized, controlled trial

被引：0
|
作者：
Wang, Jiyao [1 ]
Wang, Jiang-bin [2 ]
Shang, Jia [3 ]
Zhou, Xin-Min [4 ]
Guo, Xiao-Lin [5 ]
Zhu, Xuan [6 ]
Meng, Li-Na [7 ]
Jiang, Hai-Xing [8 ]
Mi, Yu-Qiang [9 ]
Xu, Jian-Ming [10 ]
Yang, Jin-Hui [11 ]
机构：
[1] Fudan Univ, Zhong Shan Hosp, GI & Hepatol, Shanghai 200433, Peoples R China
[2] Jilin Univ, China Japan Union Hosp, Gastroenterol, Changchun 130023, Peoples R China
[3] Henan Prov Peoples Hosp, Dept Infect Dis, Infect Dis, Zhengzhou, Peoples R China
[4] Fourth Mil Med Univ, Xijing Hosp, Digest Dis, Xian 710032, Peoples R China
[5] Jilin Univ, Hosp 1, Digest Dis, Changchun 130023, Peoples R China
[6] Nanchang Univ, Affiliated Hosp 1, Digest Diease, Nanchang, Peoples R China
[7] Zhejiang Prov Hosp Trandit Chinese Med, Digest Dis, Hangzhou, Zhejiang, Peoples R China
[8] Guangxi Med Univ, AffiliatedHosp 1, Digest Dis, Nanning, Peoples R China
[9] Tianjin Second Peoples Hosp, Hepatol, Tianjin, Peoples R China
[10] Anhui Med Univ, Affiliated Hosp 1, Digest Dis, Hefei, Peoples R China
[11] Kunming Med Univ, Affiliated Hosp 2, Hepatol, Kunming, Peoples R China
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1465
引用
收藏
页码：925A / 925A
页数：1
相关论文
共 50 条
  • [21] RIFAXIMIN VERSUS LACTULOSE IN THE TREATMENT OF MINIMAL HEPATIC ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSIS: A PROSPECTIVE, RANDOMIZED, ACTIVE-COMPARATOR, NON-INFERIORITY TRIAL
    Goyal, O.
    Sidhu, S. S.
    Parker, R. A.
    Prasad, J.
    Kishore, H.
    Sood, A.
    Mehta, V.
    Chhina, R. S.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S526 - S526
  • [22] Treatment with a potassium-iron-phosphate-citrate complex improves PSE scores and quality of life in patients with minimal hepatic encephalopathy: a multicenter, randomized, placebo-controlled, double-blind clinical trial
    Burkard, Tanja
    Biedermann, Annette
    Herold, Christoph
    Dietlein, Michael
    Rauch, Markus
    Diefenbach, Martin
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (03) : 352 - 358
  • [23] GH is effective in treatment of short stature associated with SHOX deficiency: results of a randomized, controlled, multi-center trial
    Blum, Werner F.
    Quigley, Charmian A.
    Crowe, Brenda J.
    Cao, Dachuang
    Jung, Heike
    Ross, Judith L.
    Rappold, Gudrun
    [J]. HORMONE RESEARCH, 2006, 65 : 146 - 146
  • [24] Treatment of Pregnant Women With Fear of Childbirth Using EMDR Therapy: Results of a Multi-Center Randomized Controlled Trial
    Baas, M. A. M.
    van Pampus, M. G.
    Stramrood, C. A. I.
    Dijksman, L. M.
    Vanhommerig, J. W.
    de Jongh, A.
    [J]. FRONTIERS IN PSYCHIATRY, 2022, 12
  • [25] Histamine H1 blocker hydroxyzine improves sleep in patients with cirrhosis and minimal hepatic encephalopathy: A randomized controlled pilot trial
    Spahr, Laurent
    Coeytaux, Alessandra
    Giostra, Emiliano
    Hadengue, Antoine
    Annoni, Jean-Marie
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (04): : 744 - 753
  • [26] RiMINI – the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial
    Christian Schulz
    Kerstin Schütte
    Siegfried Kropf
    Friedhelm C. Schmitt
    Riccardo Vasapolli
    Leon M. Kliegis
    Antonia Riegger
    Peter Malfertheiner
    [J]. Trials, 17
  • [27] RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial
    Schulz, Christian
    Schuette, Kerstin
    Kropf, Siegfried
    Schmitt, Friedhelm C.
    Vasapolli, Riccardo
    Kliegis, Leon M.
    Riegger, Antonia
    Malfertheiner, Peter
    [J]. TRIALS, 2016, 17
  • [28] A randomized, multi-center, double-blinded, placebo controlled, investigator-initiated trial to assess the impact of L-carnitine administration on the quality of life in the liver cirrhosis with covert hepatic encephalopathy
    Yoon, Eileen
    Jun, Dae Won
    Ahn, Sang Bong
    Cho, Yong Kyun
    Song, Do Seon
    Jeong, Jaeyoon
    Kim, Hee Yeon
    Jung, Young Kul
    Song, Myeong Jun
    Kim, Hyoung Su
    Kim, Sung Eun
    Jeong, Soung Won
    Kim, Sang Gyune
    Lee, Tae Hee
    Ryu, Hokyoung
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 : S4 - S4
  • [29] EFFECTS OF NUTRITIONAL THERAPY ON COGNITIVE FUNCTIONS AND HEALTH RELATED QUALITY OF LIFE IN PATIENTS OF LIVER CIRRHOSIS WITH MINIMAL HEPATIC ENCEPHALOPATHY - AN OPEN LABEL RANDOMIZED CONTROLLED TRIAL
    Maharshi, S.
    Sharma, B. Chander
    Srivastava, S.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S366 - S367
  • [30] Sorafenib improves survival in a large multi-center, randomized, placebo-controlled phase III trial in patients with hepatocellular carcinoma
    Llovet, J.
    Mazzaferro, V.
    Ricci, S.
    Hilgard, P.
    Raoul, J.
    Zeuzem, S.
    Shan, M.
    Moscovici, M.
    Voliotis, D.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 261 - 261
12345